<p>Hims
&amp; Hers Health, Inc. (NYSE:HIMS - 獲取免費報告) 週五下跌了 0.9%。該股最低交易價為 33.22 美元，最後交易價為 34.07 美元。在交易中，共成交了 7,643,464 股，較平均交易量 13,064,865 股下降了 41%。該股此前收盤價為 34.39 美元。</p>
<p>獲取 <strong>Hims &amp; Hers Health</strong> 的提醒：</p>
<h2>分析師評級變動</h2>
<ul>
<li>錯過了 Hims &amp; Hers 的上漲？Clover Health 可能是下一個</li>
</ul>
<p>HIMS 最近成為幾份研究報告的主題。花旗集團在週四的報告中重申了對 Hims &amp; Hers Health 的 &#34;賣出&#34; 評級，並設定了 27.00 美元的目標價。Canaccord Genuity Group 在 2 月 19 日的報告中將 Hims &amp; Hers Health 的目標價從 38.00 美元上調至 68.00 美元，並給予該股 &#34;買入&#34; 評級。摩根士丹利在 2 月 18 日的研究報告中將 Hims &amp; Hers Health 的評級從 &#34;超配&#34; 下調至 &#34;同等權重&#34;，並將該股的目標價從 42.00 美元上調至 60.00 美元。BTIG Research 在 1 月 7 日的研究報告中開始覆蓋 Hims &amp; Hers Health 的股票。他們給予該公司 &#34;買入&#34; 評級，並設定了 35.00 美元的目標價。最後，Leerink Partners 在 2 月 25 日的研究報告中將 Hims &amp; Hers Health 的目標價從 24.00 美元上調至 40.00 美元，並給予該股 &#34;市場表現&#34; 評級。兩位股票研究分析師對該股給予了賣出評級，七位給予了持有評級，六位給予了買入評級。根據 MarketBeat.com 的數據，Hims &amp; Hers Health 目前的平均評級為 &#34;持有&#34;，平均目標價為 37.23 美元。</p>
<p><strong>閲讀我們對 HIMS 的最新股票分析</strong></p>
<h2>Hims &amp; Hers Health 股票表現</h2>
<ul>
<li>華爾街最受關注：目前的兩隻高度被做空的股票</li>
</ul>
<p>該公司的市值為 79.7 億美元，市盈率為 81.33，貝塔值為 1.37。該公司的 50 日移動平均價格為 37.45 美元，200 日移動平均價格為 27.31 美元。</p>
<p>Hims &amp; Hers Health (NYSE:HIMS - 獲取免費報告) 最近於 2 月 24 日發佈了季度財報。該公司報告每股收益（EPS）為 0.11 美元，超出分析師一致預期的 0.09 美元，超出幅度為 0.02 美元。Hims &amp; Hers Health 的淨利潤率為 8.19%，股本回報率為 10.97%。該公司季度收入為 4.8114 億美元，而一致預期為 4.9456 億美元。平均而言，股票分析師預測 Hims &amp; Hers Health, Inc. 本年度每股收益將為 0.29 美元。</p>
<h2>內部交易活動</h2>
<ul>
<li>MarketBeat 週迴顧 – 02/17 - 02/21</li>
</ul>
<p>在其他消息中，內部人士 Soleil Boughton 於 2 月 18 日出售了 4,152 股該公司的股票。該股票以平均價格 60.69 美元出售，總交易額為 251,984.88 美元。交易後，該內部人士現在直接持有 157,345 股公司股票，價值約為 9,549,268.05 美元。這筆交易代表了他們持股的 2.57% 的減少。該出售在與 SEC 的法律文件中披露，可以通過此鏈接訪問。此外，內部人士 Michael Chi 於 12 月 10 日出售了 7,259 股 Hims &amp; Hers Health 股票。該股票以平均價格 32.25 美元出售，總價值為 234,102.75 美元。出售後，該內部人士現在直接持有 184,947 股公司股票，價值約為 5,964,540.75 美元。這筆交易代表了他們持股的 3.78% 的減少。該出售的披露可以在這裏找到。在過去的一個季度中，內部人士共出售了 1,062,011 股公司股票，價值為 36,892,724 美元。當前 17.71% 的股票由公司內部人士持有。</p>
<h2>Hims &amp; Hers Health 的機構交易</h2>
<p>機構投資者和對沖基金最近對該公司的持倉進行了調整。Creative Planning 在第三季度將其在 Hims &amp; Hers Health 的持倉增加了 18.1%。Creative Planning 目前持有 25,925 股公司股票，價值 478,000 美元，在此期間又購買了 3,979 股。Robeco Institutional Asset Management B.V. 在第三季度購買了 Hims &amp; Hers Health 的新頭寸，價值約為 604,000 美元。QRG Capital Management Inc. 在第三季度將其在 Hims &amp; Hers Health 的持倉增加了 3.9%。QRG Capital Management Inc. 目前持有 162,029 股公司股票，價值 2,985,000 美元，在此期間又購買了 6,077 股。Olympiad Research LP 在第三季度購買了 Hims &amp; Hers Health 的新頭寸，價值約為 262,000 美元。最後，Principal Financial Group Inc. 在第三季度將其在 Hims &amp; Hers Health 的持倉增加了 102.0%。Principal Financial Group Inc. 目前持有 290,414 股公司股票，價值 5,349,000 美元，在此期間又購買了 146,621 股。當前 63.52% 的股票由機構投資者持有。</p>
<h2>關於 Hims &amp; Hers Health</h2>
<p>(獲取免費報告)</p>
<p>Hims &amp; Hers Health, Inc. 運營一個遠程醫療諮詢平台。它將消費者與醫療專業人員連接，使他們能夠獲得心理健康、性健康、皮膚病和初級護理的醫療服務。該公司成立於 2017 年，總部位於加利福尼亞州舊金山。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票超過 Hims &amp; Hers Health</li>
<li>特殊目的收購公司 (SPAC) 你需要知道的事項</li>
<li>Myers Industries 是否準備突破？</li>
<li>低市盈率增長股票：解鎖投資機會</li>
<li>BigBear.ai 的 25% 暴跌是虛驚一場還是火災銷售？</li>
<li>股票市場升級：它們是什麼？</li>
<li>Broadcom 確認其人工智能前景：股票即將創下新高</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 Hims &amp; Hers Health 嗎？</h2>
<p>在考慮 Hims &amp; Hers Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Hims &amp; Hers Health 並不在名單上。</p>
<p>雖然 Hims &amp; Hers Health 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

HIMS

<p>Hims & Hers Health（紐約證券交易所代碼：HIMS）股價下跌 0.9%，至 34.07 美元，交易量較平均水平下降 41%。分析師的評級不一，花旗集團維持 27 美元的 “賣出” 評級，而 Canaccord Genuity 將目標價上調至 68 美元，並給予 “買入” 評級。該公司報告第四季度每股收益為 0.11 美元，超出預期，但營收為 4.8114 億美元，未達到預期。內部交易活動包括 Soleil Boughton 和 Michael Chi 的股票出售，內部人士持有 17.71% 的股份。Hims & Hers 的市值為 79.7 億美元，平均目標價為 37.23 美元</p>

<p>Hims &amp; Hers Health, Inc. (NYSE:HIMS - Get Free Report) traded down 0.9% on Friday . The stock traded as low as $33.22 and last traded at $34.07. 7,643,464 shares changed hands during trading, a decline of 41% from the average session volume of 13,064,865 shares. The stock had previously closed at $34.39.</p>
<div class="lb-trans"><p>Hims
&amp; Hers Health, Inc. (NYSE:HIMS - 獲取免費報告) 週五下跌了 0.9%。該股最低交易價為 33.22 美元，最後交易價為 34.07 美元。在交易中，共成交了 7,643,464 股，較平均交易量 13,064,865 股下降了 41%。該股此前收盤價為 34.39 美元。</p>
</div><p>Get <strong>Hims &amp; Hers Health</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Hims &amp; Hers Health</strong> 的提醒：</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><ul>
<li>Missed the Hims &amp; Hers Rally? Clover Health Could Be Next</li>
</ul>
<div class="lb-trans"><ul>
<li>錯過了 Hims &amp; Hers 的上漲？Clover Health 可能是下一個</li>
</ul>
</div><p>HIMS has been the subject of several recent research reports. Citigroup reissued a &#34;sell&#34; rating and set a $27.00 price target on shares of Hims &amp; Hers Health in a report on Thursday. Canaccord Genuity Group increased their target price on shares of Hims &amp; Hers Health from $38.00 to $68.00 and gave the stock a &#34;buy&#34; rating in a report on Wednesday, February 19th. Morgan Stanley cut shares of Hims &amp; Hers Health from an &#34;overweight&#34; rating to an &#34;equal weight&#34; rating and raised their target price for the stock from $42.00 to $60.00 in a research note on Tuesday, February 18th. BTIG Research initiated coverage on shares of Hims &amp; Hers Health in a research report on Tuesday, January 7th. They issued a &#34;buy&#34; rating and a $35.00 price target for the company. Finally, Leerink Partners increased their price objective on shares of Hims &amp; Hers Health from $24.00 to $40.00 and gave the stock a &#34;market perform&#34; rating in a research note on Tuesday, February 25th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Hims &amp; Hers Health presently has an average rating of &#34;Hold&#34; and an average target price of $37.23.</p>
<div class="lb-trans"><p>HIMS 最近成為幾份研究報告的主題。花旗集團在週四的報告中重申了對 Hims &amp; Hers Health 的 &#34;賣出&#34; 評級，並設定了 27.00 美元的目標價。Canaccord Genuity Group 在 2 月 19 日的報告中將 Hims &amp; Hers Health 的目標價從 38.00 美元上調至 68.00 美元，並給予該股 &#34;買入&#34; 評級。摩根士丹利在 2 月 18 日的研究報告中將 Hims &amp; Hers Health 的評級從 &#34;超配&#34; 下調至 &#34;同等權重&#34;，並將該股的目標價從 42.00 美元上調至 60.00 美元。BTIG Research 在 1 月 7 日的研究報告中開始覆蓋 Hims &amp; Hers Health 的股票。他們給予該公司 &#34;買入&#34; 評級，並設定了 35.00 美元的目標價。最後，Leerink Partners 在 2 月 25 日的研究報告中將 Hims &amp; Hers Health 的目標價從 24.00 美元上調至 40.00 美元，並給予該股 &#34;市場表現&#34; 評級。兩位股票研究分析師對該股給予了賣出評級，七位給予了持有評級，六位給予了買入評級。根據 MarketBeat.com 的數據，Hims &amp; Hers Health 目前的平均評級為 &#34;持有&#34;，平均目標價為 37.23 美元。</p>
</div><p><strong>Read Our Latest Stock Analysis on HIMS</strong></p>
<div class="lb-trans"><p><strong>閲讀我們對 HIMS 的最新股票分析</strong></p>
</div><h2>Hims &amp; Hers Health Stock Performance</h2>
<div class="lb-trans"><h2>Hims &amp; Hers Health 股票表現</h2>
</div><ul>
<li>Wall Street’s Most Wanted: 2 Highly Shorted Stocks Right Now</li>
</ul>
<div class="lb-trans"><ul>
<li>華爾街最受關注：目前的兩隻高度被做空的股票</li>
</ul>
</div><p>The firm has a market capitalization of $7.97 billion, a PE ratio of 81.33 and a beta of 1.37. The company has a fifty day moving average price of $37.45 and a 200-day moving average price of $27.31.</p>
<div class="lb-trans"><p>該公司的市值為 79.7 億美元，市盈率為 81.33，貝塔值為 1.37。該公司的 50 日移動平均價格為 37.45 美元，200 日移動平均價格為 27.31 美元。</p>
</div><p>Hims &amp; Hers Health (NYSE:HIMS - Get Free Report) last released its quarterly earnings results on Monday, February 24th. The company reported $0.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.09 by $0.02. Hims &amp; Hers Health had a net margin of 8.19% and a return on equity of 10.97%. The company had revenue of $481.14 million for the quarter, compared to the consensus estimate of $494.56 million. On average, equities analysts predict that Hims &amp; Hers Health, Inc. will post 0.29 earnings per share for the current year.</p>
<div class="lb-trans"><p>Hims &amp; Hers Health (NYSE:HIMS - 獲取免費報告) 最近於 2 月 24 日發佈了季度財報。該公司報告每股收益（EPS）為 0.11 美元，超出分析師一致預期的 0.09 美元，超出幅度為 0.02 美元。Hims &amp; Hers Health 的淨利潤率為 8.19%，股本回報率為 10.97%。該公司季度收入為 4.8114 億美元，而一致預期為 4.9456 億美元。平均而言，股票分析師預測 Hims &amp; Hers Health, Inc. 本年度每股收益將為 0.29 美元。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>內部交易活動</h2>
</div><ul>
<li>MarketBeat Week in Review – 02/17 - 02/21</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 02/17 - 02/21</li>
</ul>
</div><p>In other news, insider Soleil Boughton sold 4,152 shares of the firm's stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $60.69, for a total transaction of $251,984.88. Following the transaction, the insider now directly owns 157,345 shares of the company's stock, valued at approximately $9,549,268.05. This trade represents a 2.57 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Michael Chi sold 7,259 shares of Hims &amp; Hers Health stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $32.25, for a total value of $234,102.75. Following the sale, the insider now directly owns 184,947 shares of the company's stock, valued at approximately $5,964,540.75. This trade represents a 3.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 1,062,011 shares of company stock valued at $36,892,724. 17.71% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在其他消息中，內部人士 Soleil Boughton 於 2 月 18 日出售了 4,152 股該公司的股票。該股票以平均價格 60.69 美元出售，總交易額為 251,984.88 美元。交易後，該內部人士現在直接持有 157,345 股公司股票，價值約為 9,549,268.05 美元。這筆交易代表了他們持股的 2.57% 的減少。該出售在與 SEC 的法律文件中披露，可以通過此鏈接訪問。此外，內部人士 Michael Chi 於 12 月 10 日出售了 7,259 股 Hims &amp; Hers Health 股票。該股票以平均價格 32.25 美元出售，總價值為 234,102.75 美元。出售後，該內部人士現在直接持有 184,947 股公司股票，價值約為 5,964,540.75 美元。這筆交易代表了他們持股的 3.78% 的減少。該出售的披露可以在這裏找到。在過去的一個季度中，內部人士共出售了 1,062,011 股公司股票，價值為 36,892,724 美元。當前 17.71% 的股票由公司內部人士持有。</p>
</div><h2>Institutional Trading of Hims &amp; Hers Health</h2>
<div class="lb-trans"><h2>Hims &amp; Hers Health 的機構交易</h2>
</div><p>Institutional investors and hedge funds have recently made changes to their positions in the company. Creative Planning increased its position in Hims &amp; Hers Health by 18.1% during the 3rd quarter. Creative Planning now owns 25,925 shares of the company's stock valued at $478,000 after purchasing an additional 3,979 shares during the period. Robeco Institutional Asset Management B.V. purchased a new position in Hims &amp; Hers Health during the third quarter valued at approximately $604,000. QRG Capital Management Inc. increased its holdings in Hims &amp; Hers Health by 3.9% during the third quarter. QRG Capital Management Inc. now owns 162,029 shares of the company's stock valued at $2,985,000 after buying an additional 6,077 shares during the period. Olympiad Research LP bought a new position in Hims &amp; Hers Health in the third quarter worth approximately $262,000. Finally, Principal Financial Group Inc. lifted its holdings in Hims &amp; Hers Health by 102.0% during the third quarter. Principal Financial Group Inc. now owns 290,414 shares of the company's stock worth $5,349,000 after buying an additional 146,621 shares during the period. 63.52% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>機構投資者和對沖基金最近對該公司的持倉進行了調整。Creative Planning 在第三季度將其在 Hims &amp; Hers Health 的持倉增加了 18.1%。Creative Planning 目前持有 25,925 股公司股票，價值 478,000 美元，在此期間又購買了 3,979 股。Robeco Institutional Asset Management B.V. 在第三季度購買了 Hims &amp; Hers Health 的新頭寸，價值約為 604,000 美元。QRG Capital Management Inc. 在第三季度將其在 Hims &amp; Hers Health 的持倉增加了 3.9%。QRG Capital Management Inc. 目前持有 162,029 股公司股票，價值 2,985,000 美元，在此期間又購買了 6,077 股。Olympiad Research LP 在第三季度購買了 Hims &amp; Hers Health 的新頭寸，價值約為 262,000 美元。最後，Principal Financial Group Inc. 在第三季度將其在 Hims &amp; Hers Health 的持倉增加了 102.0%。Principal Financial Group Inc. 目前持有 290,414 股公司股票，價值 5,349,000 美元，在此期間又購買了 146,621 股。當前 63.52% 的股票由機構投資者持有。</p>
</div><h2>About Hims &amp; Hers Health</h2>
<div class="lb-trans"><h2>關於 Hims &amp; Hers Health</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Hims &amp; Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.</p>
<div class="lb-trans"><p>Hims &amp; Hers Health, Inc. 運營一個遠程醫療諮詢平台。它將消費者與醫療專業人員連接，使他們能夠獲得心理健康、性健康、皮膚病和初級護理的醫療服務。該公司成立於 2017 年，總部位於加利福尼亞州舊金山。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Hims &amp; Hers Health</li>
<li>Special Purpose Acquisition Company (SPAC) What You Need to Know</li>
<li>Is Myers Industries Poised for a Breakout?</li>
<li>Low PE Growth Stocks: Unlocking Investment Opportunities</li>
<li>Is BigBear.ai's 25% Plunge a False Alarm or Fire Sale?</li>
<li>Stock Market Upgrades: What Are They?</li>
<li>Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過 Hims &amp; Hers Health</li>
<li>特殊目的收購公司 (SPAC) 你需要知道的事項</li>
<li>Myers Industries 是否準備突破？</li>
<li>低市盈率增長股票：解鎖投資機會</li>
<li>BigBear.ai 的 25% 暴跌是虛驚一場還是火災銷售？</li>
<li>股票市場升級：它們是什麼？</li>
<li>Broadcom 確認其人工智能前景：股票即將創下新高</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將有關此故事的任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Hims &amp; Hers Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Hims &amp; Hers Health 嗎？</h2>
</div><p>Before you consider Hims &amp; Hers Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Hims &amp; Hers Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hims &amp; Hers Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Hims &amp; Hers Health 並不在名單上。</p>
</div><p>While Hims &amp; Hers Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Hims &amp; Hers Health 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Hims & Hers Health (NYSE:HIMS) 股價下跌 0.9% - 以下是發生的事情